Skip to content

Depression: all studies

Page 661 of 1,034: studies 6,601 to 6,610 of 10,336, newest first. Back to the depression overview

Research

Ketamine in Chronic Pain: A Review.

Cureus February 1, 2024 Ana Faísco, Rita Dinis, Tânia Seixas et al. 8 citations

Ketamine has been used in the treatment of several pain syndromes, particularly those with a relevant neuropathic component. Sub-anesthetic doses of ketamine produce a potent analgesic effect, due to its inhibition of N-methyl-D-aspartate receptors and enhancement of descending inhibitory pathways. Its short-term analgesic effect is well-documented perioperatively, with an associated reduction...

DOI: 10.7759/cureus.53365 (opens in new tab) Full text (opens in new tab) Cancer pain Chronic postoperative pain Non-oncological pain Ketamine therapy +4

Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging February 1, 2024 Friederike Holze, Nirmal Singh, Matthias E. Liechti et al. 50 citations

Psychedelic compounds, including psilocybin, LSD (lysergic acid diethylamide), DMT (N,N -dimethyltryptamine), and 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), all of which are serotonin 2A receptor agonists, are being investigated as potential treatments. This review aims to summarize the current clinical research on these 4 compounds and mescaline to guide future research. Their mechanism(s)...

Vipassana Effects on Interpersonal Functioning

ScienceOpen Preprints January 31, 2024 Brett Ruehland preprint

Over the last decade, psychological researchers have begun exploring the effects of Vipassana, a meditation practice based on teachings expounded in the earliest Buddhist texts, dating back more than two-and-a-half millennia (Bodhi, 2005). Courses to learn the technique are widely available, with hundreds of thousands of participants attending residential courses at Vipassana meditation centres...

Examining the acceptability and feasibility of the Compassionate Mindful Resilience (CMR) programme in adults living with chronic kidney disease: the COSMIC study findings.

BMC nephrology January 31, 2024 Anna Wilson, Claire Carswell, Clare Mckeaveney et al. 4 citations

Individuals with chronic kidney disease experience difficult physical and psychological symptoms, that impact quality of life, and are at increased risk of anxiety and depression. Access to specialist psychological support is limited. This study aimed to support a new service development project, in collaboration with Kidney Care UK, to implement the Compassionate Mindful Resilience (CMR)...

Sex dependence of opioid-mediated responses to subanesthetic ketamine in rats

Nature Communications January 30, 2024 Tommaso Di Ianni, Sedona N. Ewbank, Marjorie R. Levinstein et al.

Subanesthetic ketamine is increasingly used for the treatment of varied psychiatric conditions, both on- and off-label. While it is commonly classified as an N -methyl D-aspartate receptor (NMDAR) antagonist, our picture of ketamine’s mechanistic underpinnings is incomplete. Recent clinical evidence has indicated, controversially, that a component of the efficacy of subanesthetic ketamine may...

One- and Two-Photon Excitable Photoswitchable Orthoand Allosteric Ligands of Class A GPCRs

Online Publication Service of Würzburg University (Würzburg University) January 30, 2024 Hubert Georg Lambert Gerwe

Photopharmacology is a vivid field of research that combines the unsurpassed spatiotemporal resolution of light with the principles of pharmacology. By introduction of synthetic chemical photoswitches into the structures of biologically active compounds, researchers can obtain control over biological processes. This is especially useful in the research of G protein-coupled receptors (GPCRs)...

DOI: 10.25972/opus-34870 (opens in new tab) Full text (opens in new tab) G protein-coupled receptor Allosteric regulation Rhodopsin Drug discovery +10

Web-Based Mindfulness Meditation as an Adjunct to Internet-Delivered Cognitive Behavioral Therapy for Public Safety Personnel: Mixed Methods Feasibility Evaluation Study.

JMIR Formative Research January 30, 2024 Caeleigh A Landry, Hugh C Mccall, Janine D Beahm et al. 7 citations

Public safety personnel (PSP) are individuals who work to ensure the safety and security of communities (eg, correctional workers, firefighters, paramedics, and police officers). PSP have a high risk of developing mental disorders and face unique barriers to traditional mental health treatments. The PSP Wellbeing Course is a transdiagnostic, internet-delivered cognitive behavioral therapy...

Interactions between classic psychedelics and serotonergic antidepressants: Effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study.

Journal of Psychopharmacology January 27, 2024 Jessica Barbut Siva, Tommaso Barba, Hannes Kettner et al. 29 citations

Background: There is growing evidence for the therapeutic effects of psychedelics. However, it is still uncertain how these drugs interact with serotonergic antidepressants (serotonin reuptake inhibitors (SRIs)). Objective: This study explores the interaction between psychedelics and SRIs in terms of therapeutic effects. The objective is to compare acute psychedelic effects and subsequent...

DOI: 10.1177/02698811231224217 (opens in new tab) Full text (opens in new tab) Psychedelics Antidepressants Mental health Drug interactions +1

Psilocybin-assisted therapy for severe alcohol use disorder: protocol for a double-blind, randomized, placebo-controlled, 7-month parallel-group phase II superiority trial.

BMC Psychiatry January 26, 2024 Laetitia Vanderijst, Felix Hever, Anne Buot et al. 11 citations

A significant number of individuals with alcohol use disorder remain unresponsive to currently available treatments, which calls for the development of new alternatives. In parallel, psilocybin-assisted therapy for alcohol use disorder has recently yielded promising preliminary results. Building on extant findings, the proposed study is set to evaluate the feasibility and preliminary clinical...

DOI: 10.1186/s12888-024-05502-y (opens in new tab) Full text (opens in new tab) Psychedelic therapy Psilocybin-assisted therapy Serotonergic psychedelics Clinical trials +3

EFECTOS PSICOLÓGICOS DE LA PSILOCIBINA EN PACIENTES CON CÁNCER TERMICO: Una revisión del alcance

LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) January 24, 2024

Psilocybin is a natural substance with hallucinogenic properties that has recently been used in the field of health. It is an alkaloid that, when associated with psychotherapy, has shown benefits in the treatment of depression and anxiety. This study aims to analyze the current state of knowledge about the psychological effects of psilocybin in patients with terminal cancer. The method used was...